PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
New date: Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 September 2024
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the “Company”), will hold an extraordinary general meeting on 2 September at 14.00 at the Company’s premises at Skiffervägen 48 in Lund.
PostNews: Press Release
PHI postpones the extraordinary general meeting until September 2, 2024
The Board of Directors of PHI AB has decided to postpone the date of the extraordinary general meeting until September 2, 2024. An updated notice for the extraordinary general meeting will be issued shortly.
PostBlog Post
Interview with John Moore
Meet John Moore, the proposed new board member for PHI. John’s extensive experience and visionary mindset make him an invaluable addition to our team. Let’s dive into his journey and what made him interested in PHI.
PostNews: Press Release
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 19 August 2024
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the “Company”), will hold an extraordinary general meeting on 19 August at 14:00 at the Company’s premises at Skiffervägen 48 in Lund.
PostNews: Press Release
Board member Leland Foster resigns due to personal reasons
PHI announces the resignation of esteemed board member Leland Foster. Mr. Foster has decided to resign from his position due to his age and his desire to retire from professional commitments. After this, the Board of Directors continues to have a quorum in accordance with the Articles of Association.
PostNews
BioStock: PHI aims for US listing
BioStock has talked to PHI’s CEO, Patrik Eschricht, to learn more about what the dual listing on the US OTCQB market means for the company and its plans for the future.
Company News
Here, you see PHI featured in recent news and find previous CEO commentaries.
New CEO commentary: “The Single-Cell Revolution”
PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.
National Institutes of Health Purchase HoloMonitor
Using HoloMonitor’s unique capability to non-invasively image and quantify cellular behavior over long time periods, scientists at the National Institute of Aging aim to understand how the heart’s “brain cells” contribute to aging.
New CEO commentary: “Understanding Skin Cancer”
PHI’s CEO and founder Peter Egelberg comments the latest research results by the scientists at the PHI/UCSF Holographic Imaging Cytometry Center of Excellence.
Scientists at UCSF-PHI Center of Excellence map the genetic progression of invasive skin cancer
Utilizing precision genetic engineering and PHI’s HoloMonitor technology, scientists at University of California, San Francisco, have for the first time been able to monitor and map how mutations break down the genetic protection against skin cancer.
